Healthcare Industry News: vertebral augmentation
News Release - March 21, 2006
Advanced Biomaterial Systems Announces Direct Sales Force for Interventional Spine and OrthopedicsCHATHAM, N.J., March 21 (HSMN NewsFeed) -- Advanced Biomaterial Systems, Inc. (ABS) has initiated the development of a direct field sales force specifically to support interventional spine and orthopedics markets, signifying a substantial commitment to the growth of its core business.
ABS has demonstrated its ability to deliver optimal products for percutaneous spine procedures through numerous developments in the past year. Its Plexis® Bone Void Filling System and CONCERT® Spine VR received FDA indication for vertebroplasty and kyphoplasty in January 2005, and CE mark earlier this year. Plexis, which utilizes patented mixing and dispensing technologies, was designed to provide optimal physician control and safety during vertebral augmentation. Concert® Spine VR, the proprietary bone cement developed by ABS, was also developed specifically for vertebral augmentation. ABS received ISO2003 certification this year for medical device design and manufacturing, a sign of its commitment to quality in all aspects of its business.
Breaking with large-company trends toward distributor sales models, ABS is committed to development of direct sales of all of its products. "A focused, direct sales force is the right business model for our current product offering, as well as the products and procedures in our development pipeline," states CEO Peter Carr. "The first critical step was to add the right person to our senior management team to head up this effort," adds Carr. In January, ABS welcomed Joey Robinson as Vice President, Marketing and Sales. "She brings direct experience from all sides of the interventional spine market, biomaterials, and orthopedics."
"We can provide unparalleled support for the physicians in these markets through a combination of dedicated service and product innovation. Our ability to focus is one of our unique strengths," comments Robinson. "ABS has superior products in its offering now, and a rich pipeline of outstanding products that will continue to enhance patient care in percutaneous procedures. The missing piece has been the dedicated field sales force that can support the physicians on a regular basis all over the US."
ABS has identified approximately 20 key geographies to be grown within the next two years; additional growth will be supported by the addition of product lines and the creation of additional territories to allow for continued service of every account.
About Advanced Biomaterial Systems
Advanced Biomaterial Systems, Inc. develops and markets proprietary biomaterials and delivery systems designed to advance procedure outcomes and patient safety. ABS products include Plexis Bone Void Filling System, a mixing and delivery system based on patented technology, and CONCERT Spine VR Radiopaque Bone Cement, which are FDA indicated for vertebroplasty and kyphoplasty; twistOR PrePack®, a patented mixing and delivery system prepackaged with CONCERT® Bone Cement for the fixation of prosthetic devices to living bone; and CONCERT® Crainoplast, a proprietary, radiopaque resinous material used for repairing cranial defects.
Source: Advanced Biomaterial Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.